Mechanisms of action of the small conductance Ca2+-activated K+-channel modulator AP30663, a novel compound being developed for treatment of atrial fibrillation in man
Event:
ESC Congress 2019
Topic:
Antiarrhythmic Pharmacotherapy
Session:
Preclinical pharmacotherapy
